197

Drug Discovery
Sub Categories on Drug Discovery
{{items.name}}
Latest Articles
Rules-based electronic triggers effectively ID missed opportunities in diagnosis

Rules-based electronic triggers effectively ID missed opportunities in diagnosis

by Lori SolomonRules-based electronic triggers (e-triggers) are useful for post hoc detection of missed opportunities in diagnosis (MODs) in emergency department visits, according to a study published
Updated on: December 19,2024
Rules-based electronic triggers effectively ID missed opportunities in diagnosis

Rules-based electronic triggers effectively ID missed opportunities in diagnosis

by Lori SolomonRules-based electronic triggers (e-triggers) are useful for post hoc detection of missed opportunities in diagnosis (MODs) in emergency department visits, according to a study published
Updated on:December 19,2024
EU health agency urges stepped-up antibiotic resistance fight

EU health agency urges stepped-up antibiotic resistance fight

Methicillin-resistantStaphylococcus aureus. Credit: NIH/NIAIDThe European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, calling for a
Updated on: December 05,2024
EU health agency urges stepped-up antibiotic resistance fight

EU health agency urges stepped-up antibiotic resistance fight

Methicillin-resistantStaphylococcus aureus. Credit: NIH/NIAIDThe European Union health agency on Monday warned that Europe was set to miss goals on reducing the use of antibiotics, calling for a
Updated on:December 05,2024
Weekly Update of Drug News-2/12/2025

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for
Updated on: December 02,2025
Weekly Update of Drug News-2/12/2025

Weekly Update of Drug News-2/12/2025

1.European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphomaOn November 19, 2025, Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has granted conditional marketing authorization for
Updated on:December 02,2025
Unexpected discovery revives abandoned breast cancer treatment

Unexpected discovery revives abandoned breast cancer treatment

byLund UniversityMolecular analyses of IGFBP7 expression in I-SPY2 and SCAN-B. Credit:npj Precision Oncology(2024). DOI: 10.1038/s41698-024-00712-9A recent study led by Lund Universi
Updated on: December 19,2024
Unexpected discovery revives abandoned breast cancer treatment

Unexpected discovery revives abandoned breast cancer treatment

byLund UniversityMolecular analyses of IGFBP7 expression in I-SPY2 and SCAN-B. Credit:npj Precision Oncology(2024). DOI: 10.1038/s41698-024-00712-9A recent study led by Lund Universi
Updated on:December 19,2024
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com